Experience in the lower extremities trophic ulcers treatment in patient with combined pathologies: varicose veins and rheumatoid arthritis

Varicose veins of the lower extremities is one of the most common diseases on Earth and its combination with other diseases is inevitable. The combination of diseases aggravates the course of each other. Rheumatoid arthritis worsens the course of varicose veins with trophic disorders – both independently – an increase in pro-inflammatory factors, a change in microcirculation, deformation of the limb axis with a violation of musculoskeletal function, and treatment of rheumatoid arthritis reduces the immune response of the body reducing the reparative capabilities of the body.
Clinical case: a patient with a long course of rheumatoid arthritis and varicose veins. For a long time he used cytostatic drugs with a subsequent transition to hormonal drugs. For about 5 years, he noted the appearance of ulcers on both shins, which took a circular shape, which significantly reduced the quality of life and did not respond to conservative treatment. He repeatedly underwent inpatient treatment with intravenous administration of general restorative and vascular drugs. He was also constantly observed in the polyclinic at the place of residence with the implementation of local treatment of ulcerative surfaces. The patient was successively treated for varicose veins by endovenous laser coagulation of the trunks of large subcutaneous veins. The second stage was performed debridement of the wound surface and skin grafting with a free perforated flap. Between the stages, the appointment of drug therapy according to clinical recommendations.
Rheumatoid arthritis and varicose veins aggravate each other, especially trophic manifestations. Treatment of such patients should be carried out by a team ofspecialists of various profiles together. Step-by-step treatment ofsuch patients with careful preparation for each of them shows excellent results. A special place is occupied by the patients’ commitment to treatment.

1. Tan MKH, Luo R, Onida S, Maccatrozzo S, Davies AH. Venous Leg Ulcer Clinical Practice Guidelines: What is AGREEd? Eur J Vasc Endovasc Surg. 2019;57(1):121–129. https://doi.org/10.1016/j.ejvs.2018.08.043.

2. Comerota A, Lurie F. Pathogenesis of venous ulcer. Semin Vasc Surg. 2015;28(1):6–14. https://doi.org/10.1053/j.semvascsurg.2015.07.003.

3. Ramelet AA. Venous ulcer healing: Considerations for an optimal protocol. Ann Dermatol Venereol. 2021;148(4):209–210. https://doi.org/10.1016/j.annder.2021.06.005.

4. Geraghty J. Complex rheumatoid venous leg ulcer. Br J Nurs. 2016;25(20):S21–S22. https://doi.org/10.12968/bjon.2019.25.Sup20.S21.

5. Serra R, Rizzuto A, Rossi A, Perri P, Barbetta A, Abdalla K et al. Skin grafting for the treatment of chronic leg ulcers - a systematic review in evidence-based medicine. Int Wound J. 2017;14(1):149–157. https://doi.org/10.1111/iwj.12575.

6. Devine T. Leg ulcers. Aust Fam Physician. 1988;17(7):564–565. Available at: https://pubmed.ncbi.nlm.nih.gov/3415573.

7. Negus D. Prevention and treatment of venous ulceration. Ann R Coll Surg Engl. 1985;67(3):144–148. Available at: https://pubmed.ncbi.nlm.nih.gov/3890671.

8. Dufour R, Sarteel AM. Venous participation in gonarthrosis, rheumatoid arthritis, and gout. Phlebologie. 1981;34(1):157–163. Available at: https://pubmed.ncbi.nlm.nih.gov/7465640.

9. Baker SR, Stacey MC, Singh G, Hoskin SE, Thompson PJ. Aetiology of chronic leg ulcers. Eur J Vasc Surg. 1992;6(3):245–251. https://doi.org/10.1016/s0950-821x(05)80313-5.

10. Morimoto N, Kuro A, Yamauchi T, Horiuchi A, Kakudo N, Sakamoto M et al. Combined use of fenestrated-type artificial dermis and topical negative pressure wound therapy for the venous leg ulcer of a rheumatoid arthritis patient. Int Wound J. 2016;13(1):137–140. https://doi.org/10.1111/iwj.12422.

11. Wood MK, Davies DM. Use of split-skin grafting in the treatment of chronic leg ulcers. Ann R Coll Surg Engl. 1995;77(3):222–223. Available at: https://pubmed.ncbi.nlm.nih.gov/7598422.

12. Tan JH, Price P, Gut I, Stacey MC, Warrington NM, Wallace HJ. Characterization of tumor necrosis factor-α block haplotypes associated with susceptibility to chronic venous leg ulcers in Caucasian patients. Hum Immunol. 2010;71(12):1214–1219. https://doi.org/10.1016/j.humimm.2010.09.001.

13. Cowin AJ, Hatzirodos N, Rigden J, Fitridge R, Belford DA. Etanercept decreases tumor necrosis factor-alpha activity in chronic wound fluid. Wound Repair Regen. 2006;14(4):421–426. https://doi.org/10.1111/j.1743-6109.2006.00141.x.

14. Vachtenheim J, Linhart K. Varicose ulcers in chronic inflammatory rheumatic diseases and collagenoses. Cas Lek Cesk. 1974;113(1):15–19. Available at: https://pubmed.ncbi.nlm.nih.gov/4434386.

15. Watkins RM. Synovial fluid ferritin in rheumatoid arthritis: an index or cause of inflammation? Br Med J (Clin Res Ed). 1981;282(6259):189–190. https://doi.org/10.1136/bmj.282.6259.189-a.

16. Nelson EA, Harper DR, Prescott RJ, Gibson B, Brown D, Ruckley CV. Prevention of recurrence of venous ulceration: randomized controlled trial of class 2 and class 3 elastic compression. J Vasc Surg. 2006;44(4):803–808. https://doi.org/10.1016/j.jvs.2006.05.051.

17. Kolluri R, Kamel O. Images in vascular medicine. Unusual etiology of painful leg ulcers. Vasc Med. 2007;12(3):255–256. https://doi.org/10.1177/1358863X07080566.

18. Milic DJ, Zivic SS, Bogdanovic DC, Karanovic ND, Golubovic ZV. Risk factors related to the failure of venous leg ulcers to heal with compression treatment. J Vasc Surg. 2009;49(5):1242–1247. https://doi.org/10.1016/j.jvs.2008.11.069.

19. Selçuk Kapısız N, Uzun Kulaoğlu T, Fen T, Kapısız HF. Potential risk factors for varicose veins with superficial venous reflux. Int J Vasc Med. 2014;2014:531689. https://doi.org/10.1155/2014/531689.